Clinical Trial Update: Evaluation of the Safety and Efficacy of Titanium-nitric Oxide-coated Stent (Optimax®) in Patients With Lesions With a Low Risk of Restenosis (Diameter ≥ 3.0 mm and Length ≤ 20 mm)

View source ↗

Summary

A completed trial evaluating the safety and efficacy of the Optimax titanium-nitric oxide-coated stent in patients with coronary artery disease and lesions with…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• Optimax Titanium-nitric Oxide-coated Stent

Snippet

Sponsor: Fundación EPIC | Conditions: Coronary Artery Disease | Status: COMPLETED